fda glp-1 warning letters october 2025 news issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading Last month, the FDA issued

FOXO4-DRI peptide vial affects insulin, cell cycle, and oxidative stress signalling

Victoza may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, severe GI side effects, hypersensitivity reactions, increased heart rate, abdominal pain, reflux, gas and dizziness

Diabetes (2004) 53:65462

High Purity Verification Components are batch-verified to support reproducibility in research settings

Commonly used products: Hyaluronic acid-based fillers (e.g., Juvederm, Restylane) for soft, natural results

Addressing these metabolic disruptions could lead to the development of more effective therapeutic strategies for managing ME/CFS, GWS, and FM